* LifeMD Inc LFMD.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 16 cents per
share.
* Revenue rose 14.1% to $33.13 million from a year ago;
analysts
expected $30.80 million.
* LifeMD Inc's reported EPS for the quarter was a loss of 15
cents.
* The mean earnings estimate of analysts had risen by
about 11.1%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
* LifeMD Inc shares had risen by 7.6% this quarter and
lost 5.7%
so far this year.
* The company reported a quarterly loss of $4.79 million.
* Wall Street's median 12-month price target for LifeMD Inc
is
$7.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
12 at 01:31 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.16 -0.15 Beat
Dec. 31 2022 -0.18 -0.40 Missed
Sep. 30 2022 -0.28 -0.26 Beat
Jun. 30 2022 -0.35 -0.45 Missed